TCT-627 Novel Sirolimus Eluting Stent With Fusion Coating Technology to Address the 'Diabetes Issue': 2-Year Result of the en-ABL e-Registry

Authors :: Dinesh Shah
Rashmit Pandya
Apurva Vasavada
Devang Desai
Sameer Dani
Pritesh Parekh
Nirav Bhalani
Luca Testa
Chirag C. Sheth
Source :: Journal of the American College of Cardiology. 74:B615
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.
Abstract: Patients with diabetes mellitus (DM) have poorer outcomes after percutaneous coronary intervention than those without diabetes. We evaluate the 2-year safety and efficacy profile of the Abluminus DES+ in patients with diabetes within the population enrolled in the large multicenter en-ABL e-registry

Subjects :: medicine.medical_specialty
education.field_of_study
ABL
business.industry
medicine.medical_treatment
Population
Stent
Percutaneous coronary intervention
medicine.disease
Internal medicine
Sirolimus
Diabetes mellitus
medicine
In patient
Cardiology and Cardiovascular Medicine
business
education
medicine.drug

Tools